All News #Library
Rare Diseases
Chiesi Snaps Up Kalvista For $1.9B, Betting Big On Rare Disease
30 Apr 2026 //
BIOSPACE
KalVista Gets EC, Swissmedic Nod for Ekterly in Angioedema
19 Sep 2025 //
PHARMAWEB
KalVista Maintains Orphan Designation for Sebetralstat in EU
11 Aug 2025 //
BUSINESSWIRE
KalVista’s Ekterly Gets UK Nod for Hereditary Angioedema
15 Jul 2025 //
BUSINESSWIRE
Orsini to Partner as Specialty Pharmacy for KalVista`s Ekterly
07 Jul 2025 //
PR NEWSWIRE
KalVista Submits NDA, Gets Orphan Status For Sebetralstat In Japan
21 Jan 2025 //
BUSINESSWIRE

Market Place
Sourcing Support